tirzepatide alternatives weight loss 2025 Semaglutide Vs Comparison Guide 2025 - Before and After

Comparing Semaglutide and Tirzepatide: Approved Uses Shared Approved Uses Both semaglutide and tirzepatide are FDA-approved for managing type 2 diabetes and aiding in chronic weight management for adults

Getting this wrong means either underdosing by half or overdosing by double

These medications, although related, have distinct uses and dosages tailored to individual needs

The regulatory uncertainty bothers many reviewers

It is sold in weekly subcutaneous injections at five doses from 2.5 mg through 15 mg, and the Phase 3 SURMOUNT trials showed average weight loss of roughly 20 to 22 percent at the highest dose over 72 weeks